Journal of Clinical Case Reports

InFlaMed Inc., One Innovation Center, Louisville, 201 E. Jefferson St. Louisville, KY 40202, USA

Publications

• Case Report   
  Reduction of Testosterone with Leuprorelin Acetate below Normal Range as Treatment of Aging Related Metastasized Prostate Cancer Not an Optimal Longer-term Standard of Care
  Author(s): Amod Kulkarni and Girish Kotwal*
  
  Background: The incidence and prevalence of prostate cancer is very high in aged individuals above 65 in the USA and across the globe, establishing it as a prominent aging-related disorder in men. Leuprolide acetate stands as a standard treatment for aging-related metastatic prostate cancer, aiming to lower testosterone levels to castrate levels. Methods: This research report presents data from a patient with metastatic prostate cancer treated with leuprolide acetate to elucidate the agent's effectiveness and limitations in managing the metastatic prostate cancer. Additionally, curcumin, yellow spice gold from turmeric that works as an anticancer agent via multiple mechanisms including reduction in the androgen receptors and known to reduce PSA levels, was also taken as a supplement. Results.. Read More»
  DOI: 10.37421/2165-7920.2025.15.1669

  Abstract HTML PDF